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Rat hepatocytefrom ADP and inorganic phosphate, attributed to the activity of a cell surface ATP
synthase, has so far only been reported in cultures of some proliferating and tumoral cell lines. We now
provide evidence showing the presence of a functionally active ecto-FoF1-ATP synthase on the plasma
membrane of normal tissue cells, i.e. isolated rat hepatocytes. Both confocal microscopy and ﬂow cytometry
analysis show the presence of subunits of F1 (α/β and γ) and Fo (FoI-PVP(b) and OSCP) moieties of ATP
synthase at the surface of rat hepatocytes. This ﬁnding is conﬁrmed by immunoblotting analysis of the
hepatocyte plasma membrane fraction. The presence of the inhibitor protein IF1 is also detected on the
hepatocyte surface. Activity assays show that the ectopic-ATP synthase can work both in the direction of ATP
synthesis and hydrolysis. A proton translocation assay shows that both these mechanisms are accompanied
by a transient ﬂux of H+ and are inhibited by F1 and Fo-targeting inhibitors. We hypothesise that ecto-FoF1-
ATP synthase may control the extracellular ADP/ATP ratio, thus contributing to intracellular pH homeostasis.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
The FoF1-ATP synthase complex is a mitochondrial inner mem-
brane-bound enzyme responsible for ATP synthesis from ADP and
inorganic phosphate (Pi) driven by a transmembrane electrochemical
proton gradient. The complex is structurally and functionally
composed of three parts: the catalytic sector F1, consisting of ﬁve
subunits with a stoichiometry of 3α,3β,γ,δ,ɛ, the H+ translocating, or
membrane integral sector Fo, and a stalk connecting F1 with Fo, both
consisting of a variable number of subunits [1–5]. In mitochondria ATP
synthesis is coupled to proton translocation from the cytosol to the
matrix space. ATP hydrolysis drives proton translocation in the reverse
direction and is selectively inhibited by the intrinsic inhibitor protein
(IF1) [6].
Recent reports show that some structural subunits of the mito-
chondrial FoF1-ATP synthase are located on the outside of the plasma
membrane of different cell lines, such as human umbilical vein
endothelial cells (HUVEC) and human hepatocarcinoma cells (HepG2)
[7–9]. In these and other proliferating cell lines an active extracellularhemistry, Biology and Physics,
ri, Italy. Tel.: +39 080 5448535;
ti).
ll rights reserved.ATP synthesis has been reported, which is attributed to an ecto-ATP
synthase [8–10]. An ecto-adenylate kinase (AK) and ecto-nucleoside
diphosphokinase (NDPK) activity have also been detected in these
cells [9–11].
To date, the role of the ecto-FoF1-ATP synthase is not yet clear. It
has been shown that angiostatin, a potent inhibitor of angiogenesis
[12,13], reduces cellular proliferation by inhibiting the ATP synthase
activity at the surface of HUVEC [7,8,14]. Martinez et al. [9] reported
that, in HepG2 cells, the high-density lipoprotein (HDL) receptor,
with high-afﬁnity for apolipoprotein A-1 (ApoA-1), is identical to the
β-chain of ATP synthase. In differentiating mouse 3T3-L1 preadipo-
cytes, Arakaki et al. [15] found that ApoA-1 can bind to the ectopic
β-chain of H+-ATP synthase, with consequent inhibition of the activity
of cell surface ATP synthase and alteration of lipidmetabolism in these
cells. However, even in the same cell line, differences have been
reported regarding the expression level and activity of ecto-FoF1-ATP
synthase [10]. It is important to underline that all the above-
mentioned studies were conducted on cultured cells, from tumoral
and/or proliferating cell lines, and some discrepancies in results have
been often attributed to the different culture conditions used, such as
the commercial medium employed, the presence or absence of fetal
bovine serum and growth factors in the culture medium [10].
The aimof this studywas to investigate the possible presence and, if
so, the activity and subunit composition of an ecto-FoF1-ATP synthase
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growth factors. To this end, we choose freshly isolated hepatocytes
which, unlike cells in culture, do not need any addition to themedium,
and represent an appropriate experimental tool, the closest to in vivo
conditions. Isolated hepatocytes in suspension are able to retain, at
least for some time, the characteristics of living cells. Hepatocyteswere
also chosen in the light of the central role of the liver in intermediary
and energy metabolism.
The present study represents the ﬁrst indication of structural and
functional connection between the catalytic and proton translocation
sectors of the ecto-FoF1-ATP synthase complex at the hepatocyte
surface. ATP synthesis and hydrolysis values are also reported.
2. Materials and methods
2.1. Chemicals
Oligomycin, CCCP, p1p5 di (Adenosin-5-) pentaphosphate (Ap5A),
collagenase Type I, BSA (fraction V fatty acid-free), antimycin A, and
ATP bioluminescence assay kit were from Sigma-Aldrich; NADH,
NADP, pyruvate kinase, lactate dehydrogenase, glucose-6-phosphate
dehydrogenase, hexokinase, ATP, ADP and phosphoenolpyruvate (PEP)
were from Roche; acrylamide, N,N′-methylenebisacrylamide, SDS and
Bradford protein assay were from Bio-Rad; ACMA, Alexa Fluor 488-
conjugated goat anti-rabbit antibody, FM 4–64 FX and horseradish
peroxidase (HRP)-conjugated goat anti-rabbit and (HRP)-conjugated
goat anti-mouse were from Molecular Probes; monoclonal antibody
against mitochondrial COX IV was from Santa Cruz.
All other chemical reagents were of analytical grade.
2.2. Preparation of isolated hepatocytes
Male Wistar rats (200–250 g) were kept in a temperature-
controlled room under an artiﬁcial light regime of 12 h light, 12 h
darkness. A commercial mash was fed for ad libitum consumption and
the animals had free access to water. All experiments were conducted
according to local and national guidelines for animal experimentation.
Hepatocytes were isolated and puriﬁed essentially according to
Seglen [16], as modiﬁed [17]. Hepatocytes were separated from other
cell types by centrifuging at 100 g for 2 min and thenwashed twice in
Krebs–Henseleit buffer (25 mM NaHCO3, 120 mM NaCl, 5 mM KCl,
1 mMKH2PO4, 2 mMMgSO4, 2.5 mMCaCl2, 20mM glucose,1% BSA) to
completely remove collagenase. Finally, hepatocytes were ﬁltered
through a 60 μm nylon ﬁlter. The integrity and viability of the cells
were conﬁrmed with a trypan blue-exclusion test and at least 95% of
the cells remained viable at the end of the preparation.
Freshly isolated hepatocyte suspensions were used in all the
experiments.
2.3. Confocal microscopy
Hepatocytes (about 2×106) were kept at 4 °C, washed with cold
PBS and then incubated for 15 min with 2% goat serum in PBS, pH 7.4.
Cells were washed three times and incubated for 1 h at 4 °C with
rabbit polyclonal antibodies against each of the FoF1-ATP synthase
subunits: anti-F1-α/β, anti-FoI-PVP(b), anti-F1-γ or anti-OSCP (ﬁnal
volume 500 μl). All antibodies were diluted 1:200 in 2% goat serum in
PBS. An aliquot of the cells (2×106; positive control) was permeabi-
lized with 100% methanol at 4 °C for 10 min, washed twice in PBS and
labelled with antibody as described above. Hepatocytes were then
washed in PBS and incubated with goat anti-rabbit IgG conjugated
with Alexa Fluor 488 (diluted 1:100 in 2% goat serum in PBS, ﬁnal
volume 500 μl) for 1 h at 4 °C in the dark; ﬁnally cells were washed
three times with PBS and ﬁxed in 4% formaldehyde in PBS. To
selectively label plasma membranes, before formaldehyde ﬁxation,
hepatocytes were incubated with a ﬂuorescent lipophilic probe (FM4–64 FX) by the procedure described by the manufacturer. Appro-
priate controls, with cells incubated either with the primary or the
secondary antibody alone, were performed. Immunolabelled hepato-
cytes were visualized under a laser scanning confocal microscope
system (LSM Pascal, Zeiss) equipped with He–Ne and Ar lasers and
coupled to an Axiovert 200 inverted microscope (Zeiss). Confocal
images were recorded using LSM 5 Pascal software.
2.4. Flow cytometry
Hepatocytes were immunostained by the same procedure and
antibodies used for confocal microscopy. After the ﬁnal wash, cells
were ﬁxed overnight at 4 °C with PBS containing 2% formaldehyde.
Control experiments were performed by cell permeabilization with
cold methanol for 10 min before incubation with primary antibodies.
After excitation at a wavelength of 488 nm, median ﬂuorescence
intensity (MFI) was determined for each sample on a FACScan ﬂow
cytometer (Becton-Dickinson) and analyzed by CELLQUEST software
(Becton-Dickinson).
2.5. Plasma membrane isolation
Plasma membranes were isolated from rat hepatocytes following
the protocol reported in [18]. Brieﬂy, hepatocytes were resuspended in
4 volumes of 0.25M STM buffer (0.25M sucrose, 5mM Tris/HCl pH 7.4,
1 mM MgCl2) and homogenized in a 10 ml Potter–Elvehjem
homogenizer using a tight-ﬁtting teﬂon-coated pestle. The homo-
genate was centrifuged at 280 g×5 min. The supernatant was saved
and the pellet was resuspended in 0.25 M STM buffer and again
centrifuged as above. The resulting supernatant was added to the ﬁrst
one and centrifuged at 1500 g×10 min. The pellet was resuspended in
0.25 M STM buffer and 2 M STM buffer was added to obtain a ﬁnal
sucrose concentration of 1.42 M. Four milliliters of the sample was
added to poly-allomer tubes and overlaid with 0.8 ml of 0.25 M STM
buffer. After ultracentrifugation at 82,000 g×60min, the pellicle at the
interface was collected, resuspended in 0.25 M STM buffer and
centrifuged at 12,000 g×10 min. The ﬁnal pellet was used as the
plasma membrane fraction.
2.6. Preparations
Mitochondria were obtained from liver homogenate as in [19].
Submitochondrial particles (SMP) were obtained by sonication of
isolated rat liver mitochondria in the presence of 4 mM EDTA (ESMP)
at pH 8.5 or in the presence of 1 mM MgATP (MgATP-SMP) [20]. The
percent of inversion of SMP was found to range from 96 to 100% [21].
Native IF1 was prepared from MgATP-SMP as in [22].
The subunits F1-α/β, F1-γ, FoI-PVP(b), and OSCP were collected by
electro-elution from SDS-PAGE in 10 mM Tris/HCl, pH 7.4, 0.01% (w/v)
SDS, 50% (v/v) glycerol [23] and used to produce speciﬁc polyclonal
antibodies. The IgG fraction was puriﬁed by a combination of
precipitation with caprylic acid and ammonium sulfate as in [24].
2.7. Electrophoresis and Western blot procedure
SDS-PAGE was performed on slab gel with linear gradient of
polyacrylamide 12–20% [25]. 30 μg proteins of ESMP or hepatocyte
plasmamembranewere subjected to SDS/PAGE and electrotransferred
to nitrocellulose in 125 mM Tris/HCl pH 8.6, 192 mM glycine, 20%
methanol (v/v) at about 100 mA for 1 h at room temperature in a
semidry apparatus. Nitrocellulose sheet were blocked with 3% BSA in
50 mM Tris/HCl pH 7.4, 0.9% NaCl (w/v) for 1 h at 37 °C and incubated
overnight at 4 °C with antibodies against rabbit anti-FoF1-ATP
synthase subunits diluted in the same buffer [5]. Moreover, to exclude
any mitochondrial contamination, nitrocellulose sheet was also
incubated in the same conditions with antibody anti-COX IV.
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rabbit and visualized using an enhanced chemiluminescence sub-
strate kit. Densitometric analysis was performed with a Camag TLC
Scanner II at 590 nm. The quantity of antigen detected was evaluated
from the computed peak area fromwhich the relative backgroundwas
subtracted.
2.8. ATP synthesis assay
2.8.1. Bioluminescent luciferase assay
Hepatocytes (about 1×106) were incubated at 37 °C with 200 μl of
HEPES buffer (150 mM NaCl, 2 mM MgCl2, 10 mM HEPES at the
indicated pH) with or without mitochondrial ATP synthase inhibitors.
After 4 min, 100 μM ADP alone or with 5 mM Pi, at the same pH of the
HEPES buffer, was added. At the time indicated, the reaction was
stopped by centrifugation (15 s at 300 g). If necessary, the resulting
supernatant was neutralized with 0.01 N NaOH or 0.01 N HCl and used
for determination of the extracellular ATP content by the biolumines-
cence assay kit according to the manufacturer's instructions. The
pellet containing hepatocytes was lysedwith 0.1 N NaOH for 10min at
room temperature. The supernatant obtained after centrifugation
(15,000 g×4 min) was neutralized with 0.1 N HCl and used for
determination of intracellular ATP as described above.
2.8.2. Spectrophotometric determination
Hepatocytes (about 1×106) were incubated at 37 °C in a mixture
containing 10 mM HEPES at the indicated pH, 150 mM NaCl, 2 mM
MgCl2, 1 mM EDTA, 20 mM glucose, 4 U/ml hexokinase and 300 μM of
the adenylate kinase inhibitor Ap5A. After 4 min, 100 μMADP alone or
with 5 mM Pi, at the same pH of the mixture, was added. The reaction
was stopped by centrifugation (as above). The supernatant was added
to a mixture containing 1 mMMgCl2, 150 mM Tris/HCl pH 7.4 and 7 U/
ml of glucose-6-phosphate dehydrogenase. NADP (1 mM) was added
and glucose-6-phosphate was determined following NADP reduction
using a dual-wavelength spectrophotometer (Beckman Coulter DU
800, wavelength couple 360/374 nm with an ɛ=2.01 mM−1).
2.9. ATP hydrolysis assay
Extracellular ATP hydrolase activity was measured by an ATP-
regenerating system [6]. Hepatocyte suspensions were incubated in a
reaction mixture containing 100 mM NaCl, 20 mM KCl, 5 mM MgCl2,Fig.1. Surface localization of FoI-PVP(b) subunit of ATP synthase in non-permeabilized hepato
Pictures show confocal optical sections taken along the z-axis, starting with the external
Magniﬁcation ×40. Representative images of three separate experiments.0.5 mM EGTA, 40 mM Tris/HCl pH 7.4, 1 mM PEP, 10 U/ml lactate
dehydrogenase, 4 U/ml pyruvate kinase, 0.1 mM NADH. The reaction
was started by ATP addition and followed by monitoring the oxidation
of NADH at 25 °C, by dual-wavelength spectrophotometer (Beckman
Coulter DU 800) at the wavelength couple 360/374 nm with an
ɛ=2.01 mM−1.
2.10. Measurement of proton conduction
Proton conduction across the plasma membrane was monitored
following ACMA ﬂuorescence quenching (excitation 410 nm, emission
490 nm) [26] using a Jasco FP6200 spectroﬂuorimeter. The reaction
mixture was the same as used for ATP assays (ATP synthesis or
hydrolysis). Hepatocytes (0.5 mg) were incubated in the ATP
synthesizing or hydrolysing buffer with or without FoF1-ATP synthase
inhibitors. After 4 min, 2 μM ACMAwas added and proton conduction
was monitored by the addition of ADP+Pi or ATP for determination of
proton conduction during ATP synthesis or hydrolysis, respectively.
2.11. Protein determination
Protein concentration was determined by using Bradford Bio-Rad
protein assay with BSA as a standard.
2.12. Statistical analysis
Results were computed with Microsoft Excel. Comparison was
made using one-way analysis of variance (ANOVA) followed by a post-
hoc Tukey's-B test. All statistical analyses were performed using an
SPSS/PC computer program. Differences were considered statistically
signiﬁcant at Pb0.05.
3. Results
3.1. Identiﬁcation of the ATP synthase subunits at the hepatocyte surface
Isolated hepatocytes obtained after in situ liver perfusion with a
collagenase solution represent the most appropriate procedure to
obtain excellent yields (≈95%) of viable cells, with 70–90% in the form
of single cells [16,27]. Therefore, hepatocyte suspensions were used
throughout this study. Following isolation, hepatocytes were imme-
diately incubated with polyclonal antibodies raised against subunitscytes. Rat hepatocytes were incubatedwith the antibody against the FoI-PVP(b) subunit.
surface of hepatocytes in (a), and ending with confocal plane inside the cells in (h).
Fig. 2. Co-localization of surface FoF1-ATP synthase subunits with FM 4–64 FX in freshly isolated hepatocytes. Non-permeabilized hepatocytes were immunostained with speciﬁc
antibodies raised against F1-α/β (section a), FoI-PVP(b) (section b), F1-γ (section c) and OSCP (section d) subunits of the FoF1-ATP synthase (green ﬂuorescence, panels .1), washed
with cold PBS and incubated with the speciﬁc plasma membrane dye FM 4–64 FX (red ﬂuorescence, panels .2). Extensive co-localization is apparent in the merged images (yellow
ﬂuorescence, panels .3). In the panels d′.1,2,3 a detail of co-localization on the hepatocyte membrane surface, using the antibody against OSCP subunit, is shown. In e.1, intact
hepatocytes were incubated with a polyclonal rabbit antibody against acetyl-CoA carboxylase. In e.2 the immunoﬂuorescence obtained with the antibody against F1-α/β subunits in
permeabilized cells is shown. Magniﬁcation ×40. Representative images of three separate experiments.
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stalk sector i.e. FoI-PVP(b) and OSCP [1,3]. After incubation with
ﬂuorochrome-conjugated secondary antibody, hepatocytes were
visualized under confocal microscopy. Fig. 1 shows images obtained
with the FoI-PVP(b) antibody; the same pattern was obtained with all
the antibodies used (data not shown). Confocal optical sectioning
through the z-axis, taken every 1.3 μm, showed extensive ﬂuorescence
at the surface of cells; no ﬂuorescencewas present in confocal sections
inside the cells. It should be noted that cells were not permeabilized
and only the cell surface is exposed to antibodies.
To rule out the possibility that the rabbit antibodies bound
aspeciﬁcally to the cell surface, hepatocytes were also incubated
with polyclonal rabbit antibody against acetyl-CoA carboxylase, a
cytosolic enzyme highly expressed in these cells [28]. Interestingly, no
ﬂuorescence was visible outside or inside the hepatocytes (Fig. 2,
panel e.1). To conﬁrm surface localization of the antibody-linked
ﬂuorescence in intact hepatocytes, a lipophilic styryl compound (FM
4–64 FX) which inserts into the outer leaﬂet of the surface membrane
was used. An extensive co-localization of the green ﬂuorescence of the
antibodies against FoF1-ATP synthase subunits (Fig. 2, F1-α/β panel a,
FoI-PVP panel b, F1-γ panel c, and OSCP panel d) with the redFig. 3. Flow cytometry analysis of the level of FoF1-ATP synthase subunits localized at the h
against F1-α/β (panel a and circles in panel d), FoI-PVP(b) (panel b and triangles in panel d),
analyzed by FACScan ﬂow cytometry. Histogram plots: trace 1, non-permeabilized cells inc
secondary and primary antibodies; trace 3, permeabilized cells incubated with both antib
hepatocytes incubated with only the secondary antibody was subtracted from each trace. V
duplicate samples±standard error (SE).ﬂuorescence of FM 4–64 FX was observed (Fig. 2). The patchy and
punctuate staining pattern, typically observed in raft proteins [18,29],
suggests that subunits of the FoF1-ATP synthase (Fig. 2, panels d′.1, d′.2
and d′.3 represent magniﬁcation of d.1, d.2 and d.3 respectively) are in
the plasma membrane rafts. A strong ﬂuorescence pattern, character-
istic of mitochondrial staining, was produced when permeabilized
cells were exposed to the F1-α/β antibody (Fig. 2, e.2).
Confocal microscopy observations were then conﬁrmed by cyto-
ﬂuorimetric analysis of freshly isolated hepatocytes incubated with
antibodies. The distribution of ﬂuorescence intensities (Fig. 3, panels a,
b and c) obtained after incubation with F1-α/β, FoI-PVP, and OSCP
antibodies (Fig. 3, plots 2), showed a noticeable ﬂuorescence increase
relative to that observed when only the secondary antibody was used
(Fig. 3, plots 1). In permeabilized cells (Fig. 3, plots 3) the intensity of
ﬂuorescence was further increased. Like in confocal microscopy,
hepatocytes were incubated with antibody against acetyl-CoA
carboxylase obtaining a MFI similar to that obtained incubating
hepatocytes with only secondary antibody (data not shown). It is
worth underlining that there was a speciﬁc saturable binding of
antibodies, directed against the different subunits of the F1 and stalk
sectors, on the hepatocyte surface (Fig. 3, panel d).epatocyte surface. Hepatocytes were incubated with primary speciﬁc antibodies raised
OSCP (panel c and square in panel d) subunits of FoF1-ATP synthase. The samples were
ubated with secondary antibody only; trace 2, non-permeabilized cells incubated with
odies. Representative histograms of three separate experiments. (Panel d) The MFI of
alues reported in the ﬁgure are means of three separate experiments performed with
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Western blot analysis, carried out with antibodies against
mitochondrial subunits of the F1 and “stalk” sectors of the FoF1-ATP
synthase complex, in rat liver ESMP and isolated plasma membrane,
conﬁrmed the presence of the enzyme subunits on the hepatocytes
plasma membrane (Fig. 4). Interestingly, a constant ratio of the
content of the immunodetected subunits between plasma membrane
and ESMP proteins was observed (insert to Fig. 4), thus indicating that
the ecto-FoF1-ATP synthase subunits are present in the same
stoichometry as in the mitochondrial complex. Using a monoclonal
antibody against COX IV (a subunit of the cytochrome oxidase
complex) as a marker of the mitochondrial inner membrane, no
immunoreaction in the plasma membrane lane was observed (Fig. 4,
lane 1) thus showing the absence of mitochondrial contamination in
the plasma membrane fraction.
3.3. Extracellular ATP synthesis
Intra- and extracellular ATP contents were determined after
incubation of isolated hepatocytes in the presence of ADP or ADP
and Pi. The measurements were performed by using a dual-
wavelength spectrophotometer and a bioluminescent assay, both
yielding similar results.
The intracellular ATP content did not change signiﬁcantly during
incubation with ADP or ADP+Pi (Fig. 5, panel a). Under the same
experimental conditions the extracellular ATP level was higher in the
presence of both ADP and Pi as compared to that obtained in theFig. 4. Comparison of the content of the FoF1-ATP synthase subunits localized on ESMP and h
isolated from hepatocytes (lane b) were subjected to SDS-PAGE in a linear 12–20% polyacry
antisera raised against: F1-α/β (column 2); F1-γ (column 3); FoI-PVP(b) (column 4); OSCP
mitochondrial COX IV (column 1). Molecular weight standards (MW-St) were detected with P
II. The areas of the bands are the means±SE of ﬁve different experiments, and are shown inpresence of ADP alone (Fig. 5, panel b). The trypan blue-exclusion
assay showed that cells were still intact at the end of the incubation
time (data not shown). These results indicate that the intracellular ATP
pool was not contributing to the extracellular ATP content and that at
the membrane surface of hepatocytes an ATP synthesizing enzyme is
really located. Extracellular ATP produced in the presence of ADP
alone was not inﬂuenced by oligomycin (known inhibitor of
mitochondrial FoF1-ATP synthase). This ATP formation was likely due
to ecto-nucleotide kinase activities. Antimycin A, a known inhibitor of
mitochondrial complex III, had no effect on extra and intracellular
oligomycin-sensitive ATP synthesis (Fig. 5, panels c and d). These
ﬁndings indicate that mitochondria don't contribute to the measured
extracellular ATP synthesis.
The oligomycin-sensitive extracellular ATP, produced in the
presence of both ADP and Pi, was depressed by the uncoupler CCCP,
or by F1-α/β antibody (Fig. 5, panel d column 4 vs 2). Extracellular ATP
synthesis was also depressed by aurovertin, a speciﬁc inhibitor of the
F1 sector of the mitochondrial ATPase [30] (data not shown). It is
worth underlining that, under the same experimental conditions,
these inhibitors had no effect on the intracellular ATP level (Fig. 5,
panel c). Thus, the ecto-FoF1-ATP synthase complex produced ATP at
the outer surface of the hepatocyte plasma membrane.
3.4. Relationship between synthesis of ATP and transmembrane ΔμH+
A transmembrane proton gradient should be used to produce ATP
by the ecto-FoF1-ATP synthase complex. To investigate this aspect,
hepatocytes were incubated in acid, neutral, or basic extracellularepatocyte plasma membranes. 30 μg proteins of ESMP (lane a) and plasma membranes
lamide gradient, electrotransferred to nitrocellulose and immunodecorated with rabbit
(column 5). Negative control is performed using monoclonal antibody raised against
onceau S. The immunodetected subunit bands were scanned using a Camag TLC scanner
the inserted table.
Fig. 5. Effect of mitochondrial FoF1-ATP synthase inhibitors on intracellular and extracellular ATP synthesis in hepatocytes. Intracellular (panels a and c) and extracellular (panels b
and d) ATP levels were determined by dual-wavelength spectrophotometric analysis. Hepatocytes were preincubated for 4 min at 37 °C at pH 7.4 with or without oligomycin (5 μg/
ml), CCCP (1 μM), or IgG-F1 (1:100) or antimycin A (5 μg/ml). ATP synthesis was started by the addition of 100 μMADP alone or 100 μMADP and 5mM Pi. At the time indicated (1 min
in panels c and d), intracellular and extracellular ATP contents were determined. Symbols: □ control (no addition); ● +100 μM ADP; ○ +100 μM ADP+5 mM Pi. Points are means of
three separate experiments performed with duplicate samples±SE. Columns are the mean of three separate experiments each performed with duplicate samples. Bars represent SE.
The extracellular ATP synthesized in 1 min by the cell surface FoF1-ATP synthase, corrected for ATP production in the absence of Pi is presented in the inserted table. Values sharing
different letters differ signiﬁcantly.
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photometry, showed a direct relationship between increase in the pH
of the extracellular medium and increase in extracellular oligomycin-
sensitive ATP synthesis (Fig. 6, panel a).
The relationship between ATP synthesis and transmembrane
proton gradient was further analyzed by direct measurement of the
intracellular pH with the ﬂuorescent probe ACMA. Acidiﬁcation of the
intracellular space, produced by activating glycolysis with glucose
addition to the hepatocyte suspension, resulted in quenching of the
ACMA ﬂuorescence due to accumulation of the probe inside the
hepatocytes (insert to Fig. 6, panel b). Addition of ADP plus Pi to the
hepatocyte suspension incubatedwith glucose resulted in a signiﬁcant
increase of the ACMA ﬂuorescence. This was prevented by omission ofPi or addition of oligomycin and reversed by the addition of the proton
conducting uncoupler CCCP (Fig. 6, panel b). Thus extracellular
synthesis of ATP is coupled to intracellular H+ consumption.
3.5. Extracellular ATP hydrolysis
ATP hydrolase activity was performed in an ATP-regenerating
system. More than 30% of the hydrolase activity was sensitive to
oligomycin (Fig. 7, column 2 vs 1). The data presented in Fig. 7 show
that the oligomycin-sensitive ecto-ATP hydrolase activity was mark-
edly inhibited by an antibody against mitochondrial F1 sector.
Addition of isolated IF1 or of an antibody against IF1 produced
inhibition or activation of ATP hydrolysis, respectively.
Fig. 6. Relationship between ATP synthesis and transmembrane ΔμH+. (Panel a) Extracellular ATP content in hepatocytes suspension was determined by dual-wavelength
spectrophotometrical analysis at different pH's as reported in the legend to Fig. 5. Symbols: (○) control; (●) oligomycin (5 μg/ml). Points are means of three separate experiments
performed with duplicate samples±SE. Values sharing different letters differ signiﬁcantly. (Panel b) Hepatocytes were incubated 4min at 37 °C in medium containing 20mM glucose
and 2 μMACMA, pH 7.4. H+ translocationwas monitored by ACMA ﬂuorescence (excitation at λ=410 nm, emission at λ=490 nm). Where indicated 100 μMADP and 5mM Pi (trace 1),
100 μM ADP (trace 2) or ADP+Pi in the presence of 5 μg/ml oligomycin (trace 3) were added. 1 μM CCCP was added at the indicated time. Traces were corrected by subtracting the
ﬂuorescence observed in hepatocytes incubated with buffer alone. In the insert, hepatocytes were incubated in the presence or absence of glucose. Data are representative of three
separate experiments carried out with duplicate samples.
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in intracellular acidiﬁcation as shown by quenching of the ACMA
ﬂuorescence. This was prevented by inhibiting ATP hydrolysis with
oligomycin or IF1 and reversed by CCCP (Fig. 8).
4. Discussion
In the last few years the dogma that the FoF1-ATP synthase
complex is strictly a component of themitochondrial innermembrane
has been abandoned. Moser et al. [7,8] ﬁrst presented data on the
presence of some mitochondrial-like proteins such as α/β subunits of
the F1 catalytic sector of the FoF1-ATP synthase complex on the surfaceFig. 7. Extracellular ATP hydrolase activity in hepatocytes, effect of inhibitors.
Hepatocytes (1 mg/ml) were incubated for 4 min at 25 °C in an ATP hydrolysing assay
medium. The hydrolase activity, measured by dual-wavelength spectrophotometer,was
started by the addition of ATP at the indicated concentrations. Hepatocytes (1 mg/ml)
were incubated without (control) or with the addition of 5 μg/ml oligomycin, IgG-F1
(1:200), 2 μM IF1 or IgG-IF1 (1:200). The values of the hydrolase activity are means of
three separate experiments performed with duplicate samples±SE. Values sharing
different letters differ signiﬁcantly.of plasma membrane of endothelial cell cultures. Subsequent reports
indicated the presence of other subunits (γ, CF6) of the F1 sector of the
ATP synthase in the plasma membrane of various proliferating cell
lines [9,10,15,31]. Moreover, it has been indicated that also IF1 appears
to be associated with the cell surface FoF1-ATP synthase [29,32,33],
operating as a speciﬁc inhibitor of the complex. Recent studies have
proposed an involvement of the complex in adipocyte differentiation
[11,15] as well as in hepatic high-density lipoprotein (HDL)Fig. 8. Hepatocyte intracellular acidiﬁcation driven by extracellular ATP hydrolase
activity. Hepatocytes (1 mg/ml) were incubated for 5 min in a medium containing:
100 mM NaCl, 20 mM KCl, 5 mM MgCl2, 0.5 mM EGTA, 40 mM Tris/HCl pH 7.4, 2 μM
ACMAwith or without inhibitors of the mitochondrial FoF1-ATP synthase complex. The
reaction was started by the addition of 1 mM ATP. ATP-driven proton pumping was
monitored following ACMA ﬂuorescence. Trace 1: control; trace 2: cells incubated as in
trace 1 in the presence of 5 μg/ml oligomycin; trace 3: cells incubated as in trace a in the
presence of 2 μM IF1. Traces were corrected by subtracting the ﬂuorescence observed in
hepatocytes incubated with the reactionmixture alone. Data are representative of three
separate experiments performed in duplicate.
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cells ectopic-ATP synthase β-chain, which is identical to the HDL
receptor, can play an important role in HDL endocytosis and that the
membrane-bound H+-ATP synthase activity is regulated by ApoA-1, a
principal plasma apolipoprotein [9,15].
In the above-mentioned studies, depending on cell type and
culture conditions, different results in extracellular ATP synthesis rate
(ranging from picomoles to nanomoles) were reported [10]. In studies
on primary human hepatocyte cultures, Fabre et al. [34] reported only
ATP hydrolysis by ecto-F1-ATPase. The presence of an ecto-ATP
synthase has been also questioned by Quillen et al. [35] who in
HUVEC did not ﬁnd any FoF1-ATP synthase activity.
To the best of our knowledge no study has been performed to date
on the ectopic H+-ATP synthase in isolated normal tissue cells and in
the absence of factors normally present in culturing conditions. As
experimental tool closest to the in vivo situation, hepatocyte
suspensions were used.
By using different techniques like confocal microscopy, ﬂow
cytometry as well as immunoblotting analysis, here we show the
presence of the whole FoF1-ATP synthase complex localized on the
outer surface of the hepatocyte plasma membrane. This complex is
able to catalyze both ATP synthesis and reverse ATP hydrolysis. F1 and
Fo subunits are present at the hepatocyte outer surface in the same
stoichiometric ratios as in the mitochondrial inner membrane (Fig. 4).
These data together with the kinetic assay of extracellular ATP
synthesis and hydrolysis and their sensitivity to speciﬁc inhibitors of
the FoF1-ATP synthase indicate that the ectopic enzyme corresponds
in structure and functional organization to the complex in the
mitochondrial membrane. The unexpected noticeable level of the
membrane surface complex (insert to Fig. 4), suggests that the ATP
synthase located in the hepatocyte plasma membrane could have a
signiﬁcant role in determining the extracellular ADP/ATP ratio.
Under conditions of acidosis induced by glycolysis, hepatocytes
synthesized, in the presence of ADP and Pi, extracellular ATP by an
oligomycin-sensitive reaction (Fig. 5). The synthesis of ATP was
associated with alkalinization of the cytoplasmic space. Dissipation of
the cytoplasmic proton gradient induced by CCCP depressed the
oligomycin-sensitive extracellular ATP synthesis. This shows that
efﬂux of H+ from the cytoplasm is responsible for the ATP synthesis
mediated by the ectopic FoF1-ATP synthase. H+ efﬂux from the cells
and H+ uptake, coupled to synthesis and hydrolysis of ATP,
respectively, were both suppressed by oligomycin. An antibody
against F1-α/β subunits prevented intracellular alkalinization coupled
to cell surface ATP synthesis.
The membrane surface FoF1-ATP synthase may play a role in
control of intracellular pH changes produced in conditions such as
liver regeneration [36], tumor [37] and ischemia [38] through the
bifunctional ability to cause H+ ﬂows in both directions during the
synthesis or hydrolysis of ATP, thus contributing to pH homeostasis.
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